Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Clinical Pharmacology

Epinephrine, auto-injectors and anaphylaxis: Challenges of dose, depth and device

Annals of Allergy, Asthma, and Immunology | May 24, 2018 Clinical Pharmacology

A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency

European Journal of Haematology | May 23, 2018 Clinical Pharmacology

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: A placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

British Journal of Dermatology | May 22, 2018 Clinical Pharmacology

Long-term omalizumab treatment: A multicenter, real-life, 5-year trial

International Archives of Allergy and Immunology | May 22, 2018 Clinical Pharmacology

Long-term clinical outcomes of high dose mepolizumab treatment for hypereosinophilic syndrome

The Journal of Allergy and Clinical Immunology: In Practice | May 15, 2018 Clinical Pharmacology

Methotrexate and azathioprine for severe atopic dermatitis: A 5-year follow-up study of a randomized controlled trial

British Journal of Dermatology | Apr 26, 2018 Clinical Pharmacology

Antibiotics in the first week of life were associated with atopic asthma at 12 years of age

Acta Pediatrica | Apr 24, 2018 Clinical Pharmacology

Predicting chronic spontaneous urticaria symptom return after omalizumab treatment discontinuation: Exploratory analysis

The Journal of Allergy and Clinical Immunology: In Practice | Apr 20, 2018 Clinical Pharmacology

Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate to severe asthma

The Journal of Allergy and Clinical Immunology: In Practice | Apr 18, 2018 Clinical Pharmacology

The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients

Rheumatology | Apr 15, 2018 Clinical Pharmacology

« Prev 1 … 47 48 49 50 51 … 61 Next »

Epinephrine, auto-injectors and anaphylaxis: Challenges of dose, depth and device

A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: A placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

Long-term omalizumab treatment: A multicenter, real-life, 5-year trial

Long-term clinical outcomes of high dose mepolizumab treatment for hypereosinophilic syndrome

Methotrexate and azathioprine for severe atopic dermatitis: A 5-year follow-up study of a randomized controlled trial

Antibiotics in the first week of life were associated with atopic asthma at 12 years of age

Predicting chronic spontaneous urticaria symptom return after omalizumab treatment discontinuation: Exploratory analysis

Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate to severe asthma

The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

The Impact of Hormonal Imbalances on Women's Health

Anaesthetic Management in Obese Patients

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Gut Health Disorders and its Management

Epinephrine, auto-injectors and anaphylaxis: Challenges of dose, depth and device

A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: A placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

Long-term omalizumab treatment: A multicenter, real-life, 5-year trial

Long-term clinical outcomes of high dose mepolizumab treatment for hypereosinophilic syndrome

Methotrexate and azathioprine for severe atopic dermatitis: A 5-year follow-up study of a randomized controlled trial

Antibiotics in the first week of life were associated with atopic asthma at 12 years of age

Predicting chronic spontaneous urticaria symptom return after omalizumab treatment discontinuation: Exploratory analysis

Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate to severe asthma

The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

The Impact of Hormonal Imbalances on Women's Health

Anaesthetic Management in Obese Patients

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Gut Health Disorders and its Management

Select Specialty

Select Topic